Exenatide once a week assisted more patients in reaching the majority of ADA-recommended therapeutic goals than treatment with sitagliptin, pioglitazone, or insulin glargine
Nanomedicine Nanobiotechnology 8, 2345
Was it 2 weeks ago or 4 weeks ago
Bleeding Risk The most common adverse reactions when combining GLP-1R agonists with traditional antithrombotic drugs such as aspirin, clopidogrel, or direct oral anticoagulants (DOACs) include gastrointestinal symptoms of nausea, vomiting, abdominal cramping, and increased bleeding risks
Despite these side effects, the overall safety profile of retatrutide remains favorable, with additional Phase III trials needed to further evaluate its long-term effects and any potential adverse events